Etzer Darout

Stock Analyst at BMO Capital

(3.17)
# 1,178
Out of 4,755 analysts
104
Total ratings
32.47%
Success rate
6.95%
Average return

Stocks Rated by Etzer Darout

Q32 Bio
Feb 11, 2025
Downgrades: Market Perform
Price Target: $22$3
Current: $2.70
Upside: +11.11%
IGM Biosciences
Jan 10, 2025
Downgrades: Market Perform
Price Target: $21$2
Current: $1.32
Upside: +51.52%
Exelixis
Dec 20, 2024
Downgrades: Market Perform
Price Target: $36$40
Current: $34.92
Upside: +14.55%
Tourmaline Bio
Dec 6, 2024
Initiates: Outperform
Price Target: $50
Current: $13.03
Upside: +283.73%
Protagonist Therapeutics
Dec 6, 2024
Initiates: Outperform
Price Target: $62
Current: $36.81
Upside: +68.43%
Nurix Therapeutics
Dec 6, 2024
Initiates: Outperform
Price Target: $35
Current: $16.83
Upside: +108.02%
Kymera Therapeutics
Dec 6, 2024
Initiates: Market Perform
Price Target: $55
Current: $34.24
Upside: +60.63%
Jasper Therapeutics
Dec 6, 2024
Initiates: Outperform
Price Target: $63
Current: $5.19
Upside: +1,113.87%
Arvinas
Nov 20, 2024
Maintains: Outperform
Price Target: $90$88
Current: $18.83
Upside: +367.46%
Acrivon Therapeutics
Nov 14, 2024
Maintains: Outperform
Price Target: $28$27
Current: $5.10
Upside: +429.41%
Maintains: Outperform
Price Target: $132$134
Current: $81.14
Upside: +65.15%
Reiterates: Outperform
Price Target: $32$34
Current: $16.16
Upside: +110.40%
Reiterates: Outperform
Price Target: $46$48
Current: $19.05
Upside: +151.97%
Maintains: Market Perform
Price Target: $118$120
Current: $106.87
Upside: +12.29%
Maintains: Outperform
Price Target: $34$38
Current: $35.93
Upside: +5.76%
Reiterates: Outperform
Price Target: $19$26
Current: $4.28
Upside: +508.19%
Maintains: Outperform
Price Target: $26$25
Current: $5.80
Upside: +331.41%
Maintains: Market Perform
Price Target: $8$5
Current: $2.38
Upside: +110.08%
Reiterates: Outperform
Price Target: $20
Current: $3.23
Upside: +520.16%
Maintains: Outperform
Price Target: $84$91
Current: $40.05
Upside: +127.22%
Maintains: Market Perform
Price Target: $7$6
Current: $1.20
Upside: +400.00%
Maintains: Market Perform
Price Target: $3.25$3.59
Current: $0.79
Upside: +356.98%
Maintains: Outperform
Price Target: $123$122
Current: $114.53
Upside: +6.52%
Maintains: Outperform
Price Target: $80$82
Current: $73.62
Upside: +11.38%
Reiterates: Buy
Price Target: $12
Current: $2.53
Upside: +374.82%
Maintains: Outperform
Price Target: $20$19
Current: $5.62
Upside: +238.08%
Upgrades: Buy
Price Target: $170
Current: $266.94
Upside: -36.32%
Initiates: Buy
Price Target: $84
Current: $7.59
Upside: +1,006.72%
Initiates: Buy
Price Target: $54
Current: $50.33
Upside: +7.30%
Maintains: Buy
Price Target: $27$38
Current: $50.22
Upside: -24.33%
Maintains: Outperform
Price Target: $54$52
Current: $2.17
Upside: +2,301.85%